Glass House Brands (GLAS) Operating Leases (2020 - 2026)
Glass House Brands' (GLAS) quarterly Operating Leases came in at $2.9 million in Q1 2026, down 55.15% year-on-year from $6.5 million in Q1 2025, and up 2.27% on a QoQ basis from $2.9 million in Q4 2025.
Glass House Brands (GLAS) Operating Leases (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Operating Leases data on file, last reported at $2.9 million in Q1 2026.
- On a quarterly basis, Operating Leases fell 55.15% year-over-year to $2.9 million in Q1 2026; TTM through Mar 2026 was $2.9 million, a 55.15% decrease from a year earlier, with the FY2025 full-year figure at $2.9 million, down 58.19% from the prior year.
- Operating Leases for Q1 2026 stood at $2.9 million, up from $2.9 million in the prior quarter.
- Over the last five years, Operating Leases for GLAS reached as high as $9.9 million in Q4 2022 and fell as low as $2.8 million in Q1 2022.
- Historically, Operating Leases has averaged $6.3 million across 5 years, with a median of $6.9 million in 2024.
- Across the five-year window, Operating Leases jumped 244.07% in 2022 and sank 58.19% in 2025, its largest moves.
- Year by year, Operating Leases stood at $9.9 million in 2022, then decreased by 21.86% to $7.7 million in 2023, then dropped by 10.96% to $6.9 million in 2024, then sank by 58.19% to $2.9 million in 2025, then grew by 2.27% to $2.9 million in 2026.
- Per Business Quant data, the three most recent Operating Leases figures were $2.9 million in Q1 2026, $2.9 million in Q4 2025, and $3.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.93 Mn |
| Dec 31, 2025 | 2.87 Mn |
| Sep 30, 2025 | 3.16 Mn |
| Jun 30, 2025 | 3.37 Mn |
| Mar 31, 2025 | 6.54 Mn |
| Dec 31, 2024 | 6.86 Mn |
| Sep 30, 2024 | 6.83 Mn |
| Jun 30, 2024 | 7.13 Mn |
| Mar 31, 2024 | 7.42 Mn |
| Dec 31, 2023 | 7.70 Mn |
| Sep 30, 2023 | 7.99 Mn |
| Jun 30, 2023 | 9.25 Mn |
| Mar 31, 2023 | 9.56 Mn |
| Dec 31, 2022 | 9.86 Mn |
| Sep 30, 2022 | 9.16 Mn |
| Jun 30, 2022 | 3.09 Mn |
| Mar 31, 2022 | 2.79 Mn |
| Dec 31, 2021 | 2.87 Mn |
| Sep 30, 2021 | 2.76 Mn |
| Mar 31, 2021 | 2.53 Mn |